Table 2.
Characteristics | n (%) |
---|---|
Baseline statin use | |
No | 118,201 (92 %) |
Yes | 10,474 (8 %) |
Baseline statin durationa | |
<1 year | 3,432 (33 %) |
1–3 years | 3,565 (34 %) |
3+ years | 3,477 (33 %) |
Baseline statin namea | |
Atorvastatin calcium | 797 (8 %) |
Fluvastatin sodium | 1,282 (12 %) |
Lovastatin | 2,846 (27 %) |
Pravastatin sodium | 2,377 (23 %) |
Simvastatin | 3,172 (30 %) |
Baseline statin typea | |
Lipophilic | 7,300 (70 %) |
Hydrophilic | 3,174 (30 %) |
Among those who reported baseline statin use